Joseph Mikhael, MD
Basic profileProfessor, Applied Cancer Research and Drug Discovery Division, Translational Genomics Research Institute · Translational Genomics Research Institute
Joseph Mikhael is Professor, Applied Cancer Research and Drug Discovery Division, Translational Genomics Research Institute at Translational Genomics Research Institute. OpenAlex indexes 386 publications with 15,180 citations (h-index 64); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Updated 20 Oct 2026
Joseph Mikhael, M.D., is Professor, Applied Cancer Research and Drug Discovery Division, Translational Genomics Research Institute. The public record shows 388 publications with 15,199 citations (h-index 64), centered on Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, Bone health and treatments. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 25 companies.
- Top research focus: Multiple Myeloma Research and Treatments
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 25 companies
Generated from the cited public record · current as of 20 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 165.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13400 E Shea Blvd
Scottsdale, AZ 85259-5404
Telephone
480-301-8000Registry record last updated 19 Nov 2008 · collected 28 Jul 2026.
Clinical trials
Updated 20 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
Industry payments
Updated 20 Oct 2026
25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year202516 payments$244,600openpaymentsdata.cms.gov ↗
- SANOFI-AVENTIS U.S. LLCProgram year202510 payments$63,305openpaymentsdata.cms.gov ↗
- Janssen Research & Development, LLCProgram year20253 payments$55,650openpaymentsdata.cms.gov ↗
Congress activity
Updated 20 Oct 2026
35 congress contributions (2007–2025) across AACR, ASCO, ASH per OpenAlex. The most recent:
- Charlotte African American MGUS project (CHAAMP): A prospective pilot study of MGUS screening in black and/or African American adults
ASH Annual Meeting
ASH2025Co-author - Advancing Patient-Centered Care to Overcome Health Disparities in Multiple Myeloma: Key Findings from a Quality Improvement Initiative
ASH Annual Meeting
ASH2024Presenting author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Network
Updated 20 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 20 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
myeloma.org/people/joseph-mikhael-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 20 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tgen.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tgen.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗
Editorial & leadership roles
journal and society appointments- Medical Advisor
International Myeloma Foundation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗ - Treasurer
American Society of Hematology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hematology.org ↗ - Editorial Board Member
Journal of Clinical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗ - Chair
Diversity, Equity and Inclusion Council, Translational Genomics Research Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tgen.org ↗ - Active Member
International Myeloma Working Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tgen.org ↗
- Mayo Clinic Resident and Fellow Association Hall of Fame
'Educator of the Year'
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tgen.org ↗
Secondary affiliations
appointments beyond the home institution- Consultant Hematologist and Director of Myeloma Research
HonorHealth Research Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tgen.org ↗ - Affiliate
City of Hope Cancer Center, Phoenix, AZ
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗
Media & interviews
press, podcasts and appearances- Podcast: 'Frailty
Innovation, and the Future of Myeloma Treatment' (American Journal of Managed Care)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajmc.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myeloma.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myeloma.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Reiman, MD
Translational Genomics Research Institute
Daniel Von Hoff, MD
Translational Genomics Research Institute
Aleksandar Sekulic, MD
Translational Genomics Research Institute
Eric Bonnem, MD
Translational Genomics Research Institute
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Jeffrey Miller, MD
University of Minnesota Medical School
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”